Novartis AG Logo

Novartis AG

ISIN: CH0012005267 | Ticker: NOVN | LEI: 5493007HIVTX6SY6XD66
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Switzerland

About Novartis AG

Company Description

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.

Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.

Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

Year founded

1859

Served area

Worldwide

Headcount

110,000

Headquarters

Lichtstrasse 35, 4002 Basel – Switzerland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
21.11.23 None Executive member Sell CHF 1.00
27.09.23 None Executive member Sell CHF 1.00
12.06.23 None Executive member Sell CHF 260,113.56
16.05.23 None Executive member Sell CHF 1,200,359.19
23.05.22 None Executive member Sell CHF 84,085.12
27.04.22 None Executive member Sell CHF 1,765,600.80
04.03.22 None Non-Executive member Buy CHF 195,000.00
04.03.22 None Non-Executive member Buy CHF 180,000.00
28.02.22 None Executive member Sell CHF 80,880.00
25.02.22 None Executive member Sell CHF 16,076.00

Capital markets information

ISIN

CH0012005267

LEI

5493007HIVTX6SY6XD66

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

SIX Swiss Exchange

Stock Index

SMI

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.